Vertex Pharmaceuticals and CRISPR Therapeutics' gene-editing drug is the only sickle cell disease gene therapy on the market for young children.

Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.

Pediatric hospital medicine is rapidly advancing with new research focusing on clinical management, quality improvement, health equity, and technology. This summary highlights the top articles from ...

The Area Housing Commission ignored repeated requests to repair a Pensacola family's broken AC. Now a 7-year-old is hospitalized and can't be released until it's fixed.

Jonathan M. Sterling poses with children during a community outreach activity, reflecting his longstanding support for child welfare initiatives. —Photo from the Jonathan M.

During the spring semester, prestigious national and international organizations recognized Brown University faculty for ...

Minister of Health Dr. Haitham Mohamed Ibrahim met on Monday in his office in Khartoum with the Wali of Kassala State, Major General (Ret.) Al-Sadiq Mohamed Al-Azraq, in the presence of the ...

Abstract: High Flow Nasal Cannula (HFNC) therapy is commonly used in infants hospitalized with bronchiolitis, but its early indication remains challenging. This study proposes an explainable machine ...

Player recovery and the technological advances to aid it are a big part of any team's World Cup process. We experienced it ...

After a 333-day hospital stay and a heart transplant, 2-year-old Irie Gellis participated in the 2026 National Transplant ...

Abstract: Pediatric appendicitis diagnosis continues to be a clinical challenge owing to its nonspecific presentation and the potential for both misdiagnosis and inappropriate surgical intervention.

The Advanced Research Projects Agency for Health (ARPA-H) Making Obstetrics Care Smart (MOCS) program has awarded Children's Hospital of Philadelphia (CHOP), as part of a 9-institution team led by ...